Revolution Medicines · 1 hour ago
Director, Research Scientific Liaison
San Francisco Bay Area
Full-time
Onsite
Director/Executive
$204K/yr - $255K/yr
12+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The role serves as a strategic and scientific liaison between the RVMD Research organization and various internal and external partners, requiring strong operational and communication skills to support oncology drug discovery initiatives.
Health CareLife ScienceMedical
Responsibilities
Lead efforts to develop and define a robust strategy for review, prioritization and implementation of Research activities to support the business needs of various internal partners including R&D Leadership, Medical Affairs, Commercial and Investor Relations groups
Serve as a single point of contact accountable for the sourcing, collation and review of scientific materials to support training and public disclosures at scientific conferences and meetings
Leverage strong cross-functional skills to coordinate and facilitate collaborations with key stakeholders across the organization, including R&D, Medical Affairs, Commercial, Project Management, and Legal to enable aforementioned activities
Partner with Research Leadership to develop and implement an efficient and sustainable approach to RVMD’s collaborations with external academic partners
Prioritization of preclinical research proposals and RVMD review and approval of scientific materials intended for public disclosure at scientific conferences and meetings
Streamline communication and decision-making processes to optimize management of both internal and external relationships for members of Biology leadership team within the context of the above activities
Identify current and future needs and evolve capabilities of scientific liaison function to adapt to rapidly increasing scale and complexity of our RAS(ON) portfolio and the broader organization
Pro-actively work with key stakeholders across the organization to maintain a detailed understanding of the portfolio and its drivers
Qualification
Required
PhD scientist with 12+ years of related experience including strong operational talents, solid judgement, strong communication skills, and the ability to balance multiple complex projects
10+ years' experience in the biotech/pharmaceutical industry
Experience with Oncology drug discovery, including familiarity with key activities that follow progression of drug candidates from Research to Clinical Development and Commercialization
Able to pivot flexibly from strategy to operations and explain interconnections to collaborators with a wide variety of backgrounds and disciplines, including senior management and external stakeholders
Clear and concise communication style, in particular for scientific subject matter, with an ability to synthesize facts and insights into business-relevant, actionable recommendations
Ability to apply rigorous logic, creativity and ingenuity to develop solutions to complex problems
Strong interpersonal skills, including the ability to make decisions and influence others, and build and maintain positive work relationships with all levels in a dynamic and fast-paced organization
Keen attention to detail
Preferred
Experience in academic collaborator management, portfolio management, portfolio planning or similar function(s) is preferred
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
2025-12-18
2025-12-18
Company data provided by crunchbase